Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease (Q37984036)

26 August 2017

Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease (English)

1 reference

26 August 2017

cardiovascular disease

1 reference

8

Winfried März

1 reference

26 August 2017

3

Burkert Pieske

1 reference

26 August 2017

11

Stefan Pilz

1 reference

26 August 2017

Andreas Tomaschitz

1

1 reference

26 August 2017

Eberhard Ritz

2

1 reference

26 August 2017

Astrid Fahrleitner-Pammer

4

1 reference

26 August 2017

Katharina Kienreich

5

1 reference

26 August 2017

Jörg H Horina

6

1 reference

26 August 2017

Christiane Drechsler

7

1 reference

26 August 2017

Michael Ofner

9

1 reference

26 August 2017

Thomas R Pieber

10

1 reference

26 August 2017

language of work or name

1 reference

13 February 2012

1 reference

26 August 2017

Cardiovascular Research

1 reference

26 August 2017

94

1 reference

26 August 2017

10-19

1 reference

26 August 2017

1

1 reference

Mechanisms for macula densa cell release of renin

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Beta1-adrenergic blockade augments pulsatile PTH secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone: effects on the kidney and cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

FGF23 and the parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Longitudinal studies of mild primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Arterial stiffness in mild primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone and parathyroid hormone: a complex and clinically relevant relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Control of aldosterone secretion: a model for convergence in cellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Chronic renal failure is a state of cellular calcium toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Control of calcium homeostasis by angiotensin II in adrenal glomerulosa cells through activation of p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Modulation of Ca2+ channels by atrial natriuretic peptide in the bovine adrenal glomerulosa cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Impact of parathyroidectomy on neutrophil cytosolic calcium in chronic kidney disease patients: a prospective parallel group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Response of adrenal cells to parathyroid hormone stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Parathyroid hormone-related protein and glucocorticoid receptor beta are regulated by cortisol in the kidney of male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Translational success stories: angiotensin receptor 1 antagonists in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone, a vasculotoxic agent--novel functions for an old hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Central role for ENaC in development of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Bone loss in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Loss of bone minerals and strength in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Diuretics and bone loss in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Hyperparathyroidism and the calcium paradox of aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Mitochondria-targeted cardioprotection in aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Calcium, mitochondria and reperfusion injury: a pore way to die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Calcium paradox of aldosteronism and the role of the parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Use of aldosterone antagonists in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone receptor antagonists: effective but often forgotten

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Renal handling of calcium and phosphate during mineralocorticoid "escape" in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Recurrent calcium nephrolithiasis associated with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

The global cost of nonoptimal blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Central mineralocorticoid receptors and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Hormone resistance at the clinical level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

A PTH/PTHrP receptor antagonist blocks the hypercalcemic response to estradiol-17β

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS092

21 January 2018

Identifiers

DOI

10.1093/CVR/CVS092

1 reference

26 August 2017

1 reference